{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:15:12Z","timestamp":1789758912304,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":72,"publisher":"Springer US","isbn-type":[{"value":"9781071633458","type":"print"},{"value":"9781071633465","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3346-5_16","type":"book-chapter","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T12:01:45Z","timestamp":1689336105000},"page":"237-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Role of Liquid Biopsies in Rheumatoid Arthritis"],"prefix":"10.1007","author":[{"given":"Lin","family":"Bo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojia","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"issue":"1","key":"16_CR1","doi-asserted-by":"publisher","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","volume":"4","author":"JS Smolen","year":"2018","unstructured":"Smolen JS et al (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4(1):18001","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"16_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"6","author":"Q Guo","year":"2018","unstructured":"Guo Q et al (2018) Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res 6(1):15","journal-title":"Bone Res"},{"issue":"6","key":"16_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"16_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cccn.2004.07.016","volume":"350","author":"S Nijenhuis","year":"2004","unstructured":"Nijenhuis S et al (2004) Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker. Clin Chim Acta 350(1):17\u201334","journal-title":"Clin Chim Acta"},{"issue":"4","key":"16_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen JS et al (2010) Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69(4):631\u2013637","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"16_CR6","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.gene.2016.02.004","volume":"583","author":"GN Goulielmos","year":"2016","unstructured":"Goulielmos GN et al (2016) Genetic data: the new challenge of personalized medicine, insights for rheumatoid arthritis patients. Gene 583(2):90\u2013101","journal-title":"Gene"},{"issue":"14","key":"16_CR7","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.3390\/ijms21144911","volume":"21","author":"DS Mikhaylenko","year":"2020","unstructured":"Mikhaylenko DS et al (2020) Genetic polymorphisms associated with rheumatoid arthritis development and Antirheumatic therapy response. Int J Mol Sci 21(14):4911","journal-title":"Int J Mol Sci"},{"issue":"2","key":"16_CR8","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s40291-019-00444-8","volume":"24","author":"D Chen","year":"2020","unstructured":"Chen D et al (2020) Liquid biopsy applications in the clinic. Mol Diagn Ther 24(2):125\u2013132","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"16_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/CCO.0000000000000267","volume":"28","author":"A Buder","year":"2016","unstructured":"Buder A, Tomuta C, Filipits M (2016) The potential of liquid biopsies. Curr Opin Oncol 28(2):130\u2013134","journal-title":"Curr Opin Oncol"},{"issue":"16","key":"16_CR10","doi-asserted-by":"publisher","first-page":"8941","DOI":"10.3390\/ijms22168941","volume":"22","author":"T Hashimoto","year":"2021","unstructured":"Hashimoto T et al (2021) Cell-free DNA in rheumatoid arthritis. Int J Mol Sci 22(16):8941","journal-title":"Int J Mol Sci"},{"issue":"9","key":"16_CR11","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1007\/s10067-021-05614-w","volume":"40","author":"T Schioppo","year":"2021","unstructured":"Schioppo T et al (2021) The role of extracellular vesicles in rheumatoid arthritis: a systematic review. Clin Rheumatol 40(9):3481\u20133497","journal-title":"Clin Rheumatol"},{"issue":"9","key":"16_CR12","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","volume":"14","author":"G Siravegna","year":"2017","unstructured":"Siravegna G et al (2017) Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol 14(9):531\u2013548","journal-title":"Nat Rev Clin Oncol"},{"issue":"1\u20132","key":"16_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1159\/000089591","volume":"21","author":"S Geiger","year":"2006","unstructured":"Geiger S et al (2006) Nucleosomes in serum of patients with early cerebral stroke. Cerebrovasc Dis 21(1\u20132):32\u201337","journal-title":"Cerebrovasc Dis"},{"issue":"1\u20132","key":"16_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.clinbiochem.2008.09.121","volume":"42","author":"I Gornik","year":"2009","unstructured":"Gornik I et al (2009) Free serum DNA is an early predictor of severity in acute pancreatitis. Clin Biochem 42(1\u20132):38\u201343","journal-title":"Clin Biochem"},{"issue":"4","key":"16_CR15","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1373\/49.4.562","volume":"49","author":"TH Rainer","year":"2003","unstructured":"Rainer TH et al (2003) Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 49(4):562\u2013569","journal-title":"Clin Chem"},{"issue":"6","key":"16_CR16","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11(6):426\u2013437","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"16_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1568-9972(02)00101-5","volume":"2","author":"M Galeazzi","year":"2003","unstructured":"Galeazzi M et al (2003) Dosage and characterization of circulating DNA: present usage and possible applications in systemic autoimmune disorders. Autoimmun Rev 2(1):50\u201355","journal-title":"Autoimmun Rev"},{"issue":"1","key":"16_CR18","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1172\/JCI107165","volume":"52","author":"D Koffler","year":"1973","unstructured":"Koffler D et al (1973) The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest 52(1):198\u2013204","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"16_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s13317-015-0066-6","volume":"6","author":"M Dunaeva","year":"2015","unstructured":"Dunaeva M et al (2015) Decreased serum cell-free DNA levels in rheumatoid arthritis. Auto Immun Highlights 6(1\u20132):23\u201330","journal-title":"Auto Immun Highlights"},{"issue":"6","key":"16_CR20","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/1756-185X.12959","volume":"20","author":"T Hashimoto","year":"2017","unstructured":"Hashimoto T et al (2017) Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis. Int J Rheum Dis 20(6):722\u2013730","journal-title":"Int J Rheum Dis"},{"issue":"2","key":"16_CR21","first-page":"139","volume":"4","author":"SA Leon","year":"1977","unstructured":"Leon SA et al (1977) Free DNA in the serum of rheumatoid arthritis patients. J Rheumatol 4(2):139\u2013143","journal-title":"J Rheumatol"},{"issue":"4","key":"16_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ejr.2016.06.005","volume":"38","author":"IT Abdelal","year":"2016","unstructured":"Abdelal IT et al (2016) Levels of plasma cell-free DNA and its correlation with disease activity in rheumatoid arthritis and systemic lupus erythematosus patients. Egypt Rheumatologist 38(4):295\u2013300","journal-title":"Egypt Rheumatologist"},{"issue":"8","key":"16_CR23","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00296-018-4055-8","volume":"38","author":"L Laukov\u00e1","year":"2018","unstructured":"Laukov\u00e1 L et al (2018) Anti-cytokine therapy and plasma DNA in patients with rheumatoid arthritis. Rheumatol Int 38(8):1449\u20131454","journal-title":"Rheumatol Int"},{"key":"16_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/192329","volume":"2015","author":"Y Wang","year":"2015","unstructured":"Wang Y et al (2015) Cyclic GMP-AMP synthase is required for cell proliferation and inflammatory responses in rheumatoid arthritis Synoviocytes. Mediat Inflamm 2015:192329","journal-title":"Mediat Inflamm"},{"issue":"7237","key":"16_CR25","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nature07710","volume":"458","author":"T Fernandes-Alnemri","year":"2009","unstructured":"Fernandes-Alnemri T et al (2009) AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458(7237):509\u2013513","journal-title":"Nature"},{"issue":"7145","key":"16_CR26","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05911","volume":"447","author":"The Wellcome Trust Case Control Consortium","year":"2007","unstructured":"The Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447(7145):661\u2013678","journal-title":"Nature"},{"issue":"6","key":"16_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nrrheum.2015.7","volume":"11","author":"K Yamamoto","year":"2015","unstructured":"Yamamoto K et al (2015) Genetics of rheumatoid arthritis in Asia\u2013present and future. Nat Rev Rheumatol 11(6):375\u2013379","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"16_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/hmg\/ddy395","volume":"28","author":"VA Laufer","year":"2019","unstructured":"Laufer VA et al (2019) Genetic influences on susceptibility to rheumatoid arthritis in African-Americans. Hum Mol Genet 28(5):858\u2013874","journal-title":"Hum Mol Genet"},{"issue":"2","key":"16_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jbspin.2014.08.006","volume":"82","author":"J Swierkot","year":"2015","unstructured":"Swierkot J et al (2015) Analysis of associations between polymorphisms within genes coding for tumour necrosis factor (TNF)-alpha and TNF receptors and responsiveness to TNF-alpha blockers in patients with rheumatoid arthritis. Joint Bone Spine 82(2):94\u201399","journal-title":"Joint Bone Spine"},{"issue":"2","key":"16_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/tpj.2015.31","volume":"16","author":"A Juli\u00e0","year":"2016","unstructured":"Juli\u00e0 A et al (2016) A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritis. Pharmacogenomics J 16(2):147\u2013150","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"16_CR31","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/17460441.2020.1682992","volume":"15","author":"F Machaj","year":"2020","unstructured":"Machaj F et al (2020) The evolution in our understanding of the genetics of rheumatoid arthritis and the impact on novel drug discovery. Expert Opin Drug Discov 15(1):85\u201399","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"16_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/tpj.2016.88","volume":"18","author":"M Maldonado-Montoro","year":"2018","unstructured":"Maldonado-Montoro M et al (2018) Influence of IL6R gene polymorphisms in the effectiveness to treatment with tocilizumab in rheumatoid arthritis. Pharmacogenomics J 18(1):167\u2013172","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"16_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00018-021-04020-4","volume":"79","author":"M Alghamdi","year":"2021","unstructured":"Alghamdi M et al (2021) Circulating extracellular vesicles and rheumatoid arthritis: a proteomic analysis. Cell Mol Life Sci 79(1):25","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"16_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gpb.2015.02.001","volume":"13","author":"J Zhang","year":"2015","unstructured":"Zhang J et al (2015) Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 13(1):17\u201324","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"16_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/253957","volume":"2013","author":"J Schageman","year":"2013","unstructured":"Schageman J et al (2013) The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int 2013:253957","journal-title":"Biomed Res Int"},{"issue":"3","key":"16_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molonc.2014.01.012","volume":"8","author":"K Valencia","year":"2014","unstructured":"Valencia K et al (2014) miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. Mol Oncol 8(3):689\u2013703","journal-title":"Mol Oncol"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"9421720","DOI":"10.1155\/2021\/9421720","volume":"2021","author":"Q Qin","year":"2021","unstructured":"Qin Q et al (2021) Systemic proteomic analysis reveals distinct Exosomal protein profiles in rheumatoid arthritis. J Immunol Res 2021:9421720","journal-title":"J Immunol Res"},{"issue":"2","key":"16_CR38","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.3892\/mmr.2014.2804","volume":"11","author":"C Shen","year":"2015","unstructured":"Shen C et al (2015) Increased serum amyloid a and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis. Mol Med Rep 11(2):1528\u20131534","journal-title":"Mol Med Rep"},{"issue":"1","key":"16_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s13075-017-1334-9","volume":"19","author":"J Yoo","year":"2017","unstructured":"Yoo J et al (2017) Exosomal amyloid a and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis. Arthritis Res Ther 19(1):119","journal-title":"Arthritis Res Ther"},{"key":"16_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s41927-018-0041-8","volume":"2","author":"H Tsuno","year":"2018","unstructured":"Tsuno H et al (2018) A proteomic analysis of serum-derived exosomes in rheumatoid arthritis. BMC Rheumatol 2:35","journal-title":"BMC Rheumatol"},{"issue":"3","key":"16_CR41","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/biof.1715","volume":"47","author":"S Dolati","year":"2021","unstructured":"Dolati S et al (2021) The role of exosomal non-coding RNAs in aging-related diseases. Biofactors 47(3):292\u2013310","journal-title":"Biofactors"},{"issue":"1","key":"16_CR42","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jcb.26205","volume":"119","author":"F Tavasolian","year":"2018","unstructured":"Tavasolian F et al (2018) Altered expression of MicroRNAs in rheumatoid arthritis. J Cell Biochem 119(1):478\u2013487","journal-title":"J Cell Biochem"},{"issue":"5","key":"16_CR43","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.21873\/invivo.12124","volume":"34","author":"MK Lim","year":"2020","unstructured":"Lim MK et al (2020) Serum Exosomal miRNA-1915-3p is correlated with disease activity of Korean rheumatoid arthritis. In Vivo 34(5):2941\u20132945","journal-title":"In Vivo"},{"issue":"7","key":"16_CR44","doi-asserted-by":"publisher","first-page":"10930","DOI":"10.1002\/jcb.28499","volume":"120","author":"Z Zakeri","year":"2019","unstructured":"Zakeri Z et al (2019) MicroRNA and exosome: key players in rheumatoid arthritis. J Cell Biochem 120(7):10930\u201310944","journal-title":"J Cell Biochem"},{"issue":"8","key":"16_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23329","volume":"34","author":"P Cheng","year":"2020","unstructured":"Cheng P, Wang J (2020) The potential of circulating microRNA-125a and microRNA-125b as markers for inflammation and clinical response to infliximab in rheumatoid arthritis patients. J Clin Lab Anal 34(8):e23329","journal-title":"J Clin Lab Anal"},{"issue":"12","key":"16_CR46","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/s41423-019-0319-9","volume":"16","author":"W Duan","year":"2019","unstructured":"Duan W et al (2019) Exosomal microRNA in autoimmunity. Cell Mol Immunol 16(12):932\u2013934","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"16_CR47","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10238-013-0271-4","volume":"15","author":"J Song","year":"2015","unstructured":"Song J et al (2015) PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis. Clin Exp Med 15(1):121\u2013126","journal-title":"Clin Exp Med"},{"issue":"3","key":"16_CR48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1089\/jir.2018.0117","volume":"39","author":"OG Shaker","year":"2019","unstructured":"Shaker OG et al (2019) Expression profile of long noncoding RNAs, lnc-Cox2, and HOTAIR in rheumatoid arthritis patients. J Interf Cytokine Res 39(3):174\u2013180","journal-title":"J Interf Cytokine Res"},{"issue":"11","key":"16_CR49","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s10067-019-04694-z","volume":"38","author":"M Moharamoghli","year":"2019","unstructured":"Moharamoghli M et al (2019) The expression of GAS5, THRIL, and RMRP lncRNAs is increased in T cells of patients with rheumatoid arthritis. Clin Rheumatol 38(11):3073\u20133080","journal-title":"Clin Rheumatol"},{"issue":"1","key":"16_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/08916934.2020.1846183","volume":"54","author":"Z Yang","year":"2021","unstructured":"Yang Z et al (2021) LncRNA GAS5 alleviates rheumatoid arthritis through regulating miR-222-3p\/Sirt1 signalling axis. Autoimmunity 54(1):13\u201322","journal-title":"Autoimmunity"},{"issue":"10","key":"16_CR51","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/1756-185X.13930","volume":"23","author":"J Cao","year":"2020","unstructured":"Cao J et al (2020) LncRNA GAS5 activates the AMPK pathway in peripheral blood mononuclear cells derived from rheumatoid arthritis patients. Int J Rheum Dis 23(10):1318\u20131327","journal-title":"Int J Rheum Dis"},{"issue":"56","key":"16_CR52","doi-asserted-by":"publisher","first-page":"95280","DOI":"10.18632\/oncotarget.20036","volume":"8","author":"D Xu","year":"2017","unstructured":"Xu D et al (2017) Long noncoding RNAs expression profile and functional networks in rheumatoid arthritis. Oncotarget 8(56):95280\u201395292","journal-title":"Oncotarget"},{"key":"16_CR53","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.3389\/fimmu.2019.02218","volume":"10","author":"S Yan","year":"2019","unstructured":"Yan S et al (2019) Long non-coding RNA HIX003209 promotes inflammation by sponging miR-6089 via TLR4\/NF-\u03baB Signaling pathway in rheumatoid arthritis. Front Immunol 10:2218","journal-title":"Front Immunol"},{"issue":"10","key":"16_CR54","doi-asserted-by":"publisher","first-page":"6440","DOI":"10.4049\/jimmunol.174.10.6440","volume":"174","author":"SH Kim","year":"2005","unstructured":"Kim SH et al (2005) Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 174(10):6440\u20136448","journal-title":"J Immunol"},{"key":"16_CR55","doi-asserted-by":"publisher","first-page":"R86","DOI":"10.1186\/ar3013","volume":"12","author":"K Murata","year":"2010","unstructured":"Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, Ito H et al (2010) Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis. Arthritis Res Ther 12:R86","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"16_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0201851","volume":"13","author":"Y Takamura","year":"2018","unstructured":"Takamura Y et al (2018) Small RNAs detected in exosomes derived from the MH7A synovial fibroblast cell line with TNF-\u03b1 stimulation. PLoS One 13(8):e0201851","journal-title":"PLoS One"},{"issue":"12","key":"16_CR57","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1039\/C9BM01761E","volume":"8","author":"J Chen","year":"2020","unstructured":"Chen J et al (2020) Exosomal miRNA-486-5p derived from rheumatoid arthritis fibroblast-like synoviocytes induces osteoblast differentiation through the Tob1\/BMP\/Smad pathway. Biomater Sci 8(12):3430\u20133442","journal-title":"Biomater Sci"},{"key":"16_CR58","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/0076-6879(94)34073-0","volume":"234","author":"MK Shigenaga","year":"1994","unstructured":"Shigenaga MK, Aboujaoude EN, Chen Q, Ames BN (1994) Assays of oxidative DNA damage biomarkers 8-oxo-2\u2032-deoxyguanosine and 8-oxoguanine in nuclear DNA and biological fluids by high-performance liquid chromatography with electrochemical detection. Methods Enzymol 234:16\u201333","journal-title":"Methods Enzymol"},{"issue":"5","key":"16_CR59","doi-asserted-by":"publisher","first-page":"R234","DOI":"10.1186\/ar787","volume":"5","author":"S Hajizadeh","year":"2003","unstructured":"Hajizadeh S et al (2003) Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther 5(5):R234\u2013R240","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"16_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13075-017-1295-z","volume":"19","author":"E Rykova","year":"2017","unstructured":"Rykova E et al (2017) Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers. Arthritis Res Ther 19(1):85","journal-title":"Arthritis Res Ther"},{"key":"16_CR61","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3389\/fimmu.2020.00662","volume":"11","author":"C Dong","year":"2020","unstructured":"Dong C et al (2020) Identification of specific joint-inflammatogenic cell-free DNA molecules from synovial fluids of patients with rheumatoid arthritis. Front Immunol 11:662","journal-title":"Front Immunol"},{"issue":"1","key":"16_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/apha.13346","volume":"228","author":"P Svenningsen","year":"2020","unstructured":"Svenningsen P, Sabaratnam R, Jensen BL (2020) Urinary extracellular vesicles: origin, role as intercellular messengers and biomarkers; efficient sorting and potential treatment options. Acta Physiol (Oxf) 228(1):e13346","journal-title":"Acta Physiol (Oxf)"},{"issue":"7","key":"16_CR63","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00018-020-03739-w","volume":"78","author":"R Vitorino","year":"2021","unstructured":"Vitorino R et al (2021) What can urinary exosomes tell us? Cell Mol Life Sci 78(7):3265\u20133283","journal-title":"Cell Mol Life Sci"},{"key":"16_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.676105","volume":"12","author":"GS Jutley","year":"2021","unstructured":"Jutley GS et al (2021) Relationship between inflammation and metabolism in patients with newly presenting rheumatoid arthritis. Front Immunol 12:676105","journal-title":"Front Immunol"},{"issue":"3","key":"16_CR65","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/cei.12598","volume":"180","author":"V Vinuela-Berni","year":"2015","unstructured":"Vinuela-Berni V et al (2015) Proportions of several types of plasma and urine microparticles are increased in patients with rheumatoid arthritis with active disease. Clin Exp Immunol 180(3):442\u2013451","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"16_CR66","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.3390\/jcm9113499","volume":"9","author":"JH Koh","year":"2020","unstructured":"Koh JH et al (2020) Development of monitoring system for assessing rheumatoid arthritis within 5 minutes using a drop of bio-fluids. J Clin Med 9(11):3499","journal-title":"J Clin Med"},{"issue":"1","key":"16_CR67","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/BOR.0000000000000017","volume":"26","author":"MK Demoruelle","year":"2014","unstructured":"Demoruelle MK, Deane KD, Holers VM (2014) When and where does inflammation begin in rheumatoid arthritis? Curr Opin Rheumatol 26(1):64\u201371","journal-title":"Curr Opin Rheumatol"},{"issue":"9","key":"16_CR68","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","volume":"14","author":"VM Holers","year":"2018","unstructured":"Holers VM et al (2018) Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat Rev Rheumatol 14(9):542\u2013557","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"16_CR69","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/mi.2011.36","volume":"4","author":"JE Bakema","year":"2011","unstructured":"Bakema JE, van Egmond M (2011) The human immunoglobulin A Fc receptor FcalphaRI: a multifaceted regulator of mucosal immunity. Mucosal Immunol 4(6):612\u2013624","journal-title":"Mucosal Immunol"},{"issue":"4","key":"16_CR70","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.3906\/sag-2102-260","volume":"51","author":"D Yaman","year":"2021","unstructured":"Yaman D et al (2021) Dental and temporomandibular joint alterations in rheumatoid arthritis patients and their association with salivary oxidative stress. Turk J Med Sci 51(4):2073\u20132080","journal-title":"Turk J Med Sci"},{"issue":"12","key":"16_CR71","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1016\/j.joms.2011.02.131","volume":"69","author":"BT Garib","year":"2011","unstructured":"Garib BT, Qaradaxi SS (2011) Temporomandibular joint problems and periodontal condition in rheumatoid arthritis patients in relation to their rheumatologic status. J Oral Maxillofac Surg 69(12):2971\u20132978","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"16_CR72","doi-asserted-by":"publisher","first-page":"13525","DOI":"10.1038\/s41598-021-93008-y","volume":"11","author":"I Tar","year":"2021","unstructured":"Tar I et al (2021) Salivary citrullinated proteins in rheumatoid arthritis and associated periodontal disease. Sci Rep 11(1):13525","journal-title":"Sci Rep"}],"container-title":["Methods in Molecular Biology","Liquid Biopsies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3346-5_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T12:11:11Z","timestamp":1689336671000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3346-5_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071633458","9781071633465"],"references-count":72,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3346-5_16","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"15 July 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}